Literature DB >> 9703243

Human neutrophil elastase degrades inter-alpha-trypsin inhibitor to liberate urinary trypsin inhibitor related proteins.

J Hirose1, T Ozawa, T Miura, M Isaji, Y Nagao, K Yamashiro, A Nii, K Kato, A Uemura.   

Abstract

Urinary trypsin inhibitor (UTI) is a physiological protease inhibitor and inter-alpha-trypsin inhibitor (ITI) is regarded as a precursor of UTI. The purpose of this study is to determine the mechanism of the UTI release from ITI. To examine this, ITI was digested by human neutrophil elastase at various concentrations, and UTI-related proteins which were of the same size as UTI were obtained. The amino acid sequence of the 15 amino acid residues at the N-terminal of UTI-related proteins, corresponded to that of UTI. The amino acid sequences of the small amount of peptides detected corresponded to those of peptides from the heavy chain1 (H1) and the heavy chain2 (H2) of ITI, suggesting that most UTI-related proteins do not combine with peptides from the H1 and H2 of ITI. It was also revealed that UTI-related proteins have several physiological activities similar to those of UTI, i.e., human trypsin inhibitory activity, human neutrophil elastase inhibitory activity, inhibition of tumor necrosis factor-alpha (TNF-alpha) production from rat macrophages and of superoxide production from rabbit leukocytes. These results demonstrated that ITI is a precursor of UTI which is digested by human neutrophil elastase to release UTI, and that its elastase inhibitory activity is derived from UTI.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703243     DOI: 10.1248/bpb.21.651

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  15 in total

Review 1.  The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.

Authors:  Megan S Lord; James Melrose; Anthony J Day; John M Whitelock
Journal:  J Histochem Cytochem       Date:  2020-07-08       Impact factor: 2.479

2.  Inter-alpha inhibitor protein administration improves survival from neonatal sepsis in mice.

Authors:  Kultar Singh; Ling Xiu Zhang; Kreso Bendelja; Ryan Heath; Shaun Murphy; Surendra Sharma; James F Padbury; Yow-Pin Lim
Journal:  Pediatr Res       Date:  2010-09       Impact factor: 3.756

3.  Urinary trypsin inhibitor attenuates LPS-induced endothelial barrier dysfunction by upregulation of vascular endothelial-cadherin expression.

Authors:  Jie Chen; Jun Wang; Chenglei Su; Wenyi Qian; Li Sun; Hao Sun; Junjie Chen; Huazhong Zhang; Jinsong Zhang
Journal:  Inflamm Res       Date:  2015-12-17       Impact factor: 4.575

4.  Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.

Authors:  Toshiharu Ueki; Keisuke Otani; Kenichiro Kawamoto; Aiko Shimizu; Naruhito Fujimura; Seigo Sakaguchi; Toshiyuki Matsui
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

5.  Effect of ulinastatin on cytokine reaction during gastrectomy.

Authors:  Ji Hun Park; Sang Hyun Kwak; Cheol Won Jeong; Hong Beom Bae; Seok Jai Kim
Journal:  Korean J Anesthesiol       Date:  2010-04-28

6.  Urinary trypsin inhibitor: miraculous medicine in many surgical situations?

Authors:  Jong In Han
Journal:  Korean J Anesthesiol       Date:  2010-04-28

7.  Urinary trypsin inhibitor ameliorates renal tissue oxygenation after ischemic reperfusion in rats.

Authors:  Satoshi Taie; Masaaki Ueki; Kosuke Chujo; Takehiko Asaga; Yasuyuki Iwanaga; Junichiro Ono; Nobuhiro Maekawa
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

8.  Ulinastatin, a protease inhibitor, may inhibit allogeneic blood transfusion-associated pro-inflammatory cytokines and systemic inflammatory response syndrome and improve postoperative recovery.

Authors:  Haihua Shu; Kuanzhi Liu; Qiulan He; Fei Zhong; Lu Yang; Qiaobo Li; Weifeng Liu; Fang Ye; Wenqi Huang
Journal:  Blood Transfus       Date:  2013-05-08       Impact factor: 3.443

9.  The effect of ulinastatin on hemostasis in major orthopedic surgery.

Authors:  Jin Young Lee; Ji Young Lee; Jin Young Chon; Ho Sik Moon; Sung Jin Hong
Journal:  Korean J Anesthesiol       Date:  2010-01-31

10.  Effects of ulinastatin on postoperative blood loss and hemostasis in atrioventricular valve surgery with cardiopulmonary bypass.

Authors:  Jae Bum Park; Seong Hyop Kim; Song Am Lee; Jin Woo Chung; Jun Seok Kim; Hyun Keun Chee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.